This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Paul H. Wender, MD; Fred W. Reimherr, MD; David R. Wood, MD
Department of Psychiatry University of Utah 50 N Medical Dr Salt Lake City, UT 84132

Arch Gen Psychiatry. 1985;42(8):840.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

Mattes et al¹ published data that suggested that stimulant medication is ineffective in relieving the symptoms of attention deficit disorder, residual type (ADDRT, or "adult hyperactivity"). Their findings are in striking contrast with our findings using methylphenidate,² pemoline,³ pargyline,⁴ and deprenyl,⁵ and a replication with methylphenidate.⁶ An examination of the article by Mattes et al¹ and a personal communication offer a possible explanation to account for their apparent failure to replicate our findings. Their subjects differed from ours in an important aspect: their scores on the Parents' Rating Scale (PRS), which is a measure of childhood hyperactivity. In their study, the mean scores for ADD with hyperactivity and ADD without hyperactivity were 10.7 and 6.7, respectively; in contrast, we found that only subjects with scores of 12 or higher (the 95th percentile or higher) showed a therapeutic response. Only seven . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?